Clinical Impacts of Allograft Biopsy in Renal Transplant Recipients 10 Years or Longer After Transplantation
Transplant International · 2024
DOI: 10.3389/ti.2024.13022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2024. Verfasst von Tomoko Namba-Hamano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Glomerular Filtration Rate, Kidney, Allografts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We aimed to investigate the clinical value of allograft biopsy performed long after renal transplantation. We retrospectively evaluated 99 allograft biopsies in recipients with transplantation vintages of 10 years or longer. Mixed-effects model showed that 1-year estimated glomerular filtration rate (eGFR) slopes after biopsy were significantly greater than those before biopsy [−3.13, −4.42 mL/min/1.73 m 2 /year, p = 0.01]. Renal biopsy changed the treatment strategies in more than half of the patients. Improvement in eGFR slopes was pronounced in 51 patients with treatment modification based on the biopsy results [2.27 (95% confidence interval (CI): 0.66, 3.89) mL/min/1.73 m 2 /year], whereas no improvement was observed in those without [0.33 (95% CI: −1.05, 1.71) mL/min/1.73 m 2 /year, P interaction = 0.001]. Among the treatment modifications, enhancement of immunosuppression (IS) led to the most remarkable improvement in eGFR slope. Patients with g scores ≥2 were more likely to receive IS enhancement than those with g scores = 0 [odds ratio; 15.0 (95% CI: 1.65, 136)]. Patients with active glomerulitis (g ≥ 1) without chronicity (cg ≤ 1) showed the most significant improvement in eGFR slope. Given the prevalence of active glomerulitis (g ≥ 1, 21%), which is responsive to treatment even long after transplantation, and the observed magnitude of eGFR slope improvement, renal biopsy can indeed improve allograft prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
- Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
- Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
- Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Zitieren
APA
Namba-Hamano, T., Hamano, T., Doi, Y., Hiraoka, A., Yonishi, H., Sakai, S., Takahashi, A., Mizui, M., Nakazawa, S., Yamanaka, K., Kakuta, Y., Imamura, R., Nonomura, N., & Isaka, Y. (2024). Clinical Impacts of Allograft Biopsy in Renal Transplant Recipients 10 Years or Longer After Transplantation. Transplant International. https://doi.org/10.3389/ti.2024.13022
Vancouver
Namba-Hamano T, Hamano T, Doi Y, Hiraoka A, Yonishi H, Sakai S, et al. Clinical Impacts of Allograft Biopsy in Renal Transplant Recipients 10 Years or Longer After Transplantation. Transplant International. 2024. doi:10.3389/ti.2024.13022
BibTeX
@article{NambaHamano2024,
author = {Namba-Hamano, Tomoko and Hamano, Takayuki and Doi, Yohei and Hiraoka, Atsuko and Yonishi, Hiroaki and Sakai, Shinsuke and Takahashi, Atsushi and Mizui, Masayuki and Nakazawa, Shigeaki and Yamanaka, Kazuaki and Kakuta, Yoichi and Imamura, Ryoichi and Nonomura, Norio and Isaka, Yoshitaka},
title = {Clinical Impacts of Allograft Biopsy in Renal Transplant Recipients 10 Years or Longer After Transplantation},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.13022}
}
EUVIMED